Sources Sought Notice - Acute Radiation Syndrome Thrombocytopenia Therapeutic

Notice ID:

SSN-BARDA-2021-ARSTT

Department/Ind. Agency:

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub-tier:

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub Command:

BARDA - ASPR / DAAPPO / BARDA DCMA

Office:

BARDA - ASPR / DAAPPO / BARDA DCMA

All Dates/Times are:

(utc-05:00) eastern standard time, new york, usa

Updated Published Date:

(utc-05:00) eastern standard time, new york, usa

Original Published Date:

0000-00-00 00:00:00

Original Response Date:

dec 22, 2021 09:00 am est

Inactive Policy:

manual

Original Inactive Date:

dec 23, 2021

Initiative:

• None***--***

Product Service Code:

an13 - health r&d services; health care services; experimental development

NAICS Code:

541714 - research and development in biotechnology (except nanobiotechnology)

Original Set Aside:

The Office of the Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) intends to use responses to this Sources Sought Notice (SSN) for planning potential future acquisitions. BARDA seeks pertinent marketplace data on availabilities and capabilities for procuring and stockpiling of Food and Drug Administration (FDA) approved medical countermeasures (MCMs) to treat thrombocytopenia, a component of the Hematopoietic Subsyndrome of Acute Radiation Syndrome (H-ARS), by stimulation of thrombopoiesis. This information is intended to strengthen BARDA’s understanding of the current and future marketplace and enhance its ability to obtain quality services economically, and to efficiently and lawfully establish potential vendor source files and listings. BARDA will not award any contracts under this notice.

O’NEILL HOUSE OFFICE BUILDING

WASHINGTON , DC 20515

USA

Primary Point of Contacts:

Richard Hall

Secondary Point of Contact:

Jonathan Gonzalez